Cyclacel Pharmaceuticals (CYCC) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CYCC is expected to report earnings to fall 15.65% to -41 cents per share on March 27

Cyclacel Pharmaceuticals CYCC Stock Earnings Reports

Q4'23

Est.

$-0.41

Q3'23

Missed

by $0.13

Q2'23

Beat

by $0.06

Q1'23

Beat

by $0.20

Q4'22

Missed

by $0.12

The last earnings report on November 13 showed earnings per share of -49 cents, missing the estimate of -36 cents. With 329.82K shares outstanding, the current market capitalization sits at 1.95M.

View a ticker or compare two or three

Compare

CYCC

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For CYCC
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of mechanism-targeted drugs to treat human cancers

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

200 Connell Drive

Phone

+1 908 517-7330

Employees

Web

https://cyclacel.com